Physician profile
Efrain Torres
NPI 1003859265
$882.14
in general payments reported to CMS, 2019-2025
18 companies · $692 in 2025
The $692 reported for 2025 was more than what 85% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.58 · 2020: $43.20 · 2021: $33.74 · 2022: $25.59 · 2023: $33.26 · 2024: $29.00 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $174.89 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $98.51 | 2024-2025 | Airsupra, Breztri |
| Viatris Specialty LLC | $87.01 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.87 | 2025 | Caplyta |
| Verona Pharma, INC. | $63.40 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $51.25 | 2021-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $50.53 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $47.52 | 2025 | Zenpep, Vowst |
| Shield Therapeutics INC | $37.62 | 2025 | |
| Abbvie INC. | $35.57 | 2025 | |
| Nestle Healthcare Nutrition INC. | $26.47 | 2020-2022 | |
| Rgh Enterprises LLC | $23.83 | 2025 | |
| Lundbeck LLC | $21.16 | 2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $20.91 | 2025 | Voquezna |
| Abbott Laboratories | $19.46 | 2025 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $18.90 | 2023 | Onpattro |
| Allergan, INC. | $17.52 | 2020 | |
| Pfizer INC. | $14.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efrain Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.